Changchun BCHT Biotechnology Co (SHSE:688276) Interest Expense : ¥-9 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Changchun BCHT Biotechnology Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Changchun BCHT Biotechnology Co's interest expense for the three months ended in Mar. 2024 was ¥ -0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-9 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Changchun BCHT Biotechnology Co's Operating Income for the three months ended in Mar. 2024 was ¥ 59 Mil. Changchun BCHT Biotechnology Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -0 Mil. Changchun BCHT Biotechnology Co's Interest Coverage for the quarter that ended in Mar. 2024 was 118.55. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Changchun BCHT Biotechnology Co Interest Expense Historical Data

The historical data trend for Changchun BCHT Biotechnology Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Changchun BCHT Biotechnology Co Interest Expense Chart

Changchun BCHT Biotechnology Co Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-8.30

-4.05

-0.33

-0.15

-0.71

Changchun BCHT Biotechnology Co Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Interest Expense	Get a 7-Day Free Trial															-	-8.30	-0.29	-0.15	-0.50

Changchun BCHT Biotechnology Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-9 Mil.

Changchun BCHT Biotechnology Co (SHSE:688276) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Changchun BCHT Biotechnology Co's Interest Expense for the three months ended in Mar. 2024 was ¥-0 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥59 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥0 Mil.

Changchun BCHT Biotechnology Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage	=	-1	*	Operating Income (Q: Mar. 2024 )	/	Interest Expense (Q: Mar. 2024 )
	=	-1	*	59.155	/	-0.499
	=	118.55

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. Changchun BCHT Biotechnology Co has enough cash to cover all of its debt. Its financial situation is stable.

Changchun BCHT Biotechnology Co (SHSE:688276) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Changchun BCHT Biotechnology Co (SHSE:688276) » Definitions » Interest Expense

Traded in Other Exchanges

N/A

Address

No. 1260, Huoju Road, High-tech Development Zone, Jilin Province, Changchun, CHN, 130012

Website

http://www.bchtpharm.com

Changchun BCHT Biotechnology Co is a biopharmaceutical enterprise specializing in the research and development, production and sales of human vaccines.

Executives

Shi Nian Min	Core technical personnel
Jiang Chun Lai	Directors, senior managers, core technical personn
Zhu Chang Lin	Core technical personnel
Wei Wei	Senior management, core technical personnel
Yu Bing	senior management
Liu Da Wei	Senior management, core technical personnel
Meng Zhao Feng	senior management
Zhang Zhe	senior management
Kong Wei	Directors, senior managers, core technical personn
Feng Da Qiang	Supervisors

Changchun BCHT Biotechnology Co (SHSE:688276) Headlines

No Headlines